LENSAR (LNSR) Competitors $14.13 -0.01 (-0.07%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$14.14 +0.01 (+0.11%) As of 03/28/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LNSR vs. CBLL, BBNX, AVNS, IRMD, BFLY, SIBN, KIDS, TMCI, DCTH, and CLPTShould you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Iradimed (IRMD), Butterfly Network (BFLY), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry. LENSAR vs. CeriBell Beta Bionics Avanos Medical Iradimed Butterfly Network SI-BONE OrthoPediatrics Treace Medical Concepts Delcath Systems ClearPoint Neuro CeriBell (NASDAQ:CBLL) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, community ranking, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment. Is CBLL or LNSR more profitable? CeriBell has a net margin of 0.00% compared to LENSAR's net margin of -34.03%. CeriBell's return on equity of 0.00% beat LENSAR's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A LENSAR -34.03%-49.02%-21.12% Do analysts rate CBLL or LNSR? CeriBell currently has a consensus target price of $32.60, suggesting a potential upside of 67.52%. LENSAR has a consensus target price of $15.00, suggesting a potential upside of 6.16%. Given CeriBell's stronger consensus rating and higher possible upside, equities analysts plainly believe CeriBell is more favorable than LENSAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00LENSAR 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals hold more shares of CBLL or LNSR? 40.2% of LENSAR shares are held by institutional investors. 38.5% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer CBLL or LNSR? CeriBell received 3 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 100.00% of users gave CeriBell an outperform vote while only 37.50% of users gave LENSAR an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes9100.00% Underperform VotesNo VotesLENSAROutperform Votes637.50% Underperform Votes1062.50% Which has preferable valuation and earnings, CBLL or LNSR? CeriBell has higher revenue and earnings than LENSAR. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$65.44M10.67N/AN/AN/ALENSAR$53.49M3.11-$14.38M-$2.72-5.19 Does the media prefer CBLL or LNSR? In the previous week, LENSAR had 12 more articles in the media than CeriBell. MarketBeat recorded 15 mentions for LENSAR and 3 mentions for CeriBell. CeriBell's average media sentiment score of 1.82 beat LENSAR's score of 0.18 indicating that CeriBell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LENSAR 1 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCeriBell beats LENSAR on 11 of the 14 factors compared between the two stocks. Remove Ads Get LENSAR News Delivered to You Automatically Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LNSR vs. The Competition Export to ExcelMetricLENSARSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$166.58M$4.35B$5.63B$7.84BDividend YieldN/A32.64%4.59%4.01%P/E Ratio-9.6828.4223.3718.70Price / Sales3.1149.43387.8490.67Price / CashN/A51.0838.1734.64Price / Book4.766.046.894.23Net Income-$14.38M$67.64M$3.20B$247.15M7 Day Performance-4.66%-5.01%-2.99%-2.18%1 Month Performance8.69%-3.28%1.63%-5.68%1 Year Performance315.96%10.64%9.45%-0.74% LENSAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNSRLENSAR0.712 of 5 stars$14.13-0.1%$15.00+6.2%+316.0%$166.58M$53.49M-9.68110High Trading VolumeCBLLCeriBellN/A$20.47-2.7%$32.60+59.3%N/A$734.22M$65.44M0.00N/ANews CoverageBBNXBeta BionicsN/A$16.61+13.2%$24.83+49.5%N/A$711.89M$53.03M0.00294Earnings ReportAnalyst RevisionNews CoverageAVNSAvanos Medical2.7063 of 5 stars$14.65+1.3%N/A-29.9%$673.81M$687.80M43.084,040High Trading VolumeIRMDIradimed4.865 of 5 stars$52.10-0.7%$72.00+38.2%+19.1%$662.45M$73.24M34.73110BFLYButterfly Network2.7529 of 5 stars$2.71+0.9%$3.00+10.9%+123.0%$657.11M$82.06M-5.88460Positive NewsHigh Trading VolumeSIBNSI-BONE3.8679 of 5 stars$15.22+3.2%$24.50+61.0%-14.2%$646.14M$167.18M-16.54350Short Interest ↑Positive NewsKIDSOrthoPediatrics4.2982 of 5 stars$24.96-0.5%$37.25+49.2%-15.2%$606.20M$204.73M-20.29200TMCITreace Medical Concepts2.5461 of 5 stars$7.97+0.3%$10.14+27.3%-35.2%$499.07M$209.36M-8.05250Short Interest ↓Positive NewsDCTHDelcath Systems3.2483 of 5 stars$13.19+4.8%$22.75+72.5%+175.7%$440.59M$37.21M-9.7760Positive NewsCLPTClearPoint Neuro2.1497 of 5 stars$13.60+6.3%$25.00+83.8%+76.0%$375.80M$31.39M-19.71110Gap Up Remove Ads Related Companies and Tools Related Companies CeriBell Competitors Beta Bionics Competitors Avanos Medical Competitors Iradimed Competitors Butterfly Network Competitors SI-BONE Competitors OrthoPediatrics Competitors Treace Medical Concepts Competitors Delcath Systems Competitors ClearPoint Neuro Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LNSR) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LNSR Stock Free LNSR Stock Alerts